News NHS and Drayson to pilot intensive care digital sensors Chelsea and Westminster Hospital to adopt Drayson wireless environment sensors.
News NHS and Drayson Technologies unveil groundbreaking digital h... NHS and Drayson Technologies unveil groundbreaking digital health deal
News NIH abandons trial of SIGA's mpox drug Another clinical trial has found that SIGA Technologies' antiviral drug TPOXX (tecovirimat) is ineffective as a treatment for mpox.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
